BNT162b2-vaccine-induced neutralization responses are immune correlates of clinical protection against SARS-CoV-2 in heart transplant recipients.

Yael PeledJignesh K PatelEhud RaananiEilon RamAlexander FardmanRoy BeigelNofar AtariLimor KlikerBayan Abd ElkaderMichal MandelboimArnon Afek

Published in: Clinical transplantation (2023)

BNT162b2-vaccine-induced neutralization responses are immune correlates of protection and confer clinical protection against COVID-19 hospitalizations.

Keyphrases

sars cov
high glucose
diabetic rats
coronavirus disease
heart failure
respiratory syndrome coronavirus
drug induced
endothelial cells
atrial fibrillation
stress induced